These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24118272)

  • 1. Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.
    Lai Q; Castro Santa E; Rico Juri JM; Pinheiro RS; Lerut J
    Transpl Int; 2014 Jan; 27(1):32-41. PubMed ID: 24118272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation.
    Xia W; Ke Q; Wang Y; Wang W; Zhang M; Shen Y; Wu J; Xu X; Zheng S
    World J Surg Oncol; 2015 Feb; 13():60. PubMed ID: 25885777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?
    Tanoglu A; Karagoz E
    Transpl Int; 2014 Aug; 27(8):e80-1. PubMed ID: 24612189
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to 'neutrophil and platelet-to-lymphocyte ratio: new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer?'.
    Lai Q; Lerut J
    Transpl Int; 2014 Aug; 27(8):e82-3. PubMed ID: 24628991
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
    Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
    Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
    Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation.
    Ismael MN; Forde J; Milla E; Khan W; Cabrera R
    Biomed Res Int; 2019; 2019():7284040. PubMed ID: 31737675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostication of inflammatory cells in liver transplantation: Is the waitlist neutrophil-to-lymphocyte ratio really predictive of tumor biology?
    McVey JC; Sasaki K; Firl DJ; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Miller CC; Hashimoto K; Aucejo FN
    Clin Transplant; 2019 Dec; 33(12):e13743. PubMed ID: 31655000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
    Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
    Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
    Xiao GQ; Yang JY; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
    Fan W; Zhang Y; Wang Y; Yao X; Yang J; Li J
    PLoS One; 2015; 10(3):e0119312. PubMed ID: 25742141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.
    Parisi I; Tsochatzis E; Wijewantha H; Rodríguez-Perálvarez M; De Luca L; Manousou P; Fatourou E; Pieri G; Papastergiou V; Davies N; Yu D; Luong T; Dhillon AP; Thorburn D; Patch D; O'Beirne J; Meyer T; Burroughs AK
    Liver Transpl; 2014 Nov; 20(11):1327-35. PubMed ID: 25088400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma].
    Wang GY; Yang Y; Zhang Q; Li H; Chen GZ; Yi SH; Xu C; Wang GS; Zhang J; Yi HM; Jiang N; Fu BS; Zhao H; Li MR; Chen YH; Cai CJ; Lu MQ; Chen GH
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1519-22. PubMed ID: 21914362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Models of Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Sánchez Segura J; León Díaz FJ; Pérez Reyes M; Cabañó Muñoz D; Sánchez Pérez B; Pérez Daga JA; Montiel Casado C; Santoyo Santoyo J
    Transplant Proc; 2020 Mar; 52(2):546-548. PubMed ID: 32037068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
    Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
    Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.